š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
Patients with type 2 diabetes mellitus are exposed to an excessive heart fa...
Status
Terminated
Location
Hannover Medical School
Start Date
2016-04-27
Trial ID
NCT02728453
Treatments Being Tested
This two-phase study was to examine if 16 weeks of treatment with sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-24
Trial ID
NCT01477853
The purpose of this study is to assess the safety and efficacy of omariglip...
Status
Completed
Location
Multiple Locations
Start Date
2013-01-11
Trial ID
NCT01755156
The purpose of this study is to evaluate the effect of JTT-851 on diabetes ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01699737
Treatments Being Tested
This study will examine the safety and efficacy of the addition of omarigli...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-18
Trial ID
NCT01704261
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of once-week...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-01
Trial ID
NCT01769378
Treatments Being Tested
This is a study to evaluate the efficacy and safety of the addition of ertu...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-16
Trial ID
NCT02630706
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of multip...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01007097